Karyopharm Therapeutics Inc. buy Piper Sandler
Start price
06.11.24
/
50%
€0.83
Target price
06.11.25
€4.67
Performance (%)
-33.98%
End price
07.11.25
-
Summary
This prediction is currently being closed. Massive losses of -33.98% have been the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for Karyopharm Therapeutics Inc. where he still thinks Karyopharm Therapeutics Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karyopharm Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Piper_Sandler for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target raised by analysts at Piper Sandler from $4.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for KPTI provided by MarketBeat
In the thread Trading Karyopharm Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
09.10.25
09.10.25
€10.31
09.10.26
09.10.26
-
25.02.25
25.02.25
Stopped prediction by Piper_Sandler for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.12.25
17.12.25
-
17.12.26
17.12.26
-
25.02.25
25.02.25